201 The scenario analysis (Table 6.2) showed that the GoYK intervention remained cost-effective for different time horizons, intervention effects, sample distributions, starting age, mortality risk, and extra costs. The assessment of multiple variations of the intervention effect (Figure 6.4) showed that GoYK would be cost-saving if it promoted at least a 1% of reduction in the transition between CKD 3/4 and ESRD. Figure 6.4 Variations of the effect of the intervention on the transition from CKD 3/4 to ESRD
RkJQdWJsaXNoZXIy MTk4NDMw